Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 453/02 (2006.01) A61K 31/439 (2006.01) A61P 1/08 (2006.01)

Patent

CA 2372238

A single crystalline polymorphic form (2S, 3S)-N-(2-methoxy-5-t-butylphenyl)methyl-2-diphenylmethyl-1-azabicyclo [2,2,2] octan-3-amine citrate monohydrate and its pharmaceutical composition. The pharmaceutical composition of the polymorphic form of the citrate monohydrate has advantageous stability for formulation to treat emesis. The administration of this pharmaceutical composition is immediate release, oral dosage form preferably by tablet or capsule or intravenous.

L'invention concerne une forme polymorphe cristalline unique (2S, 3S)-N-(méthoxy-5-t-butylphénylméthyl-2-diphénylméthyl-1-azobicyclo (2,2,2) octan-3-amine citrate(monohydrate de citrate) et sa composition pharmaceutique. Ladite composition est de forme polymorphe, si le monohydrate de citrate présente une stabilité avantageuse sur le plan de sa préparation destinée à traiter l'émèse. L'administration de cette composition pharmaceutique est à libération immédiate, et s'effectue par dosage buccal, sous forme de comprimé ou de gélules, ou par voie intraveineuse.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1345251

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.